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 BACKGROUND  RESULTS 
● Frailty is an age-related state of decreased 
physiological reserves characterized by a 
weakened response to stressors and an 
increased risk of poor clinical outcomes. 
 
● Frailty predisposes individuals to progressive 
decline in different functional domains (Figure 
1) and contributes to the onset of geriatric 
syndromes (Clegg et al., 2013; Fried et al., 2004).  
 
 OBJECTIVES 
● Objective: Summarize the best available evidence in relation to the effectiveness of the 
interventions in preventing progression of frailty in older adults. 
 
- What is the effectiveness of interventions in preventing or reducing frailty in older 
adults, and how does it vary with degree of frailty? 
- Are there factors that influence the effectiveness of those interventions?  
- What is the economic feasibility of interventions for frailty? 
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 METHODS 
● The review process was based on the Joanna Briggs Institute procedures (2014). 
 CONCLUSIONS 
Figure 1. Trajectories of functional decline  
Figure 2. Flowchart for the search and 
selection process 
!!! Studies where the selection of participants was based on specific disease/illness or  
terminal diagnosis were excluded.  
● Publication date: from January 2001 to November 2015 
● Languages: English, Portuguese, Spanish, Italian, Dutch 
● Databases for published studies: CINAHL, MEDLINE, SCOPUS, EMBASE, Cochrane Central 
Register of Controlled Trials, Scielo 
● Databases for unpublished studies: ProQuest Theses and Dissertations, OpenGrey, Banco 
de teses de CAPES, Dissertations Abstracts Online (e-Thos) 
 INCLUSION CRITERIA 
 SEARCH STRATEGY 
 
● Population: Participants aged 65 and over, explicitly identified as pre-frail or frail and 
receiving health care and support services in any type of setting. 
 
● Intervention: Interventions focusing on the prevention of frailty progress. 
 
● Comparator: Usual care, alternative therapeutic interventions or no intervention. 
 
● Outcomes:  Frailty indicated by any validated scale or measurement or index, clinical 
outcomes (including functional and cognitive capacity, activities of daily living, quality of 
life, depression, drugs and prescription, adverse outcomes, etc.), economic outcomes. 
 ASSESSMENT OF METHODOLOGICAL QUALITY 
 REFERENCES 
● Assessment tool: Joanna Briggs Institute Critical Appraisal Checklists for (i) Experimental 
Studies, (ii) Comparable Cohort and Case Control, (iii) Descriptive and Case Series, (iv) 
Economic Evaluations; all checklists were  completed by two independent reviewers. 
 
● Initially, the clinical component was evaluated, being included only the studies with ≥ 5 
affirmative responses on the appraisal checklist;  
● Then, the economic component was evaluated. No cut-off point for inclusion was applied. 
● 21 RCTs included (Figure 2), 2 of them 
focused on economic outcomes 
 
● Main methodological strengths: 
- identical procedures used for outcomes 
assessment in control and intervention  
groups (100%) 
- use of statistical analysis (100%) 
 
● Main methodological weaknesses: 
- lack of participant blinding (90%) 
- differences in treatment of the 
intervention and control groups (62%) 
- lack of cultural adaptation of the 
assessment tools (57%) 
 
● High variability in the frailty definition and 
operationalization of frailty indicators was 
also observed.  
● Interventions described in the included studies: physical exercise (n=7), 
nutritional supplementation (n=3), hormone replacement (n=1), individually 
tailored management of frailty (n=5), combined treatment (n=4), home visits 
(n=4), group sessions (n=3), cognitive training (n=1), psychological therapy 
(n=1), educational session by a geriatrician (n=1). 
● This systematic review has demonstrated mixed effectiveness of frailty 
interventions, but with clear evidence of the usefulness of such interventions in 
careful evidence based circumstances, supporting clinical investment of 
resources into frailty intervention.  
● Interventions reducing frailty or postponing its progression: exercise programs 
conducted in group, protein supplementation with physical exercise or alone, 
combined treatment, cognitive training.  
● Not universally effective: group meetings, home visits and multidisciplinary 
approach. 
●  Lack of efficacy: home-based exercise or exercise performed individually, hormone 
supplementation, problem solving therapy. 
 FRAILTY 
● Different interventions had different effects on secondary outcomes. The positive 
changes were most frequently observed for functional capacity, mental health 
and analytical parameters.   
 
● The economic analyses focused on the individually tailored management of frailty 
in comparison to usual care.  They showed that the experimental intervention: 
 
- is more effective and less costly for very frail older adults from community; 
 
- is more effective and equally costly for frail community-dwelling older 
adults and frail outpatients; 
  
- is more effective and more costly for frail inpatients. 
 SECONDARY OUTCOMES 
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● Evidence to support the malleability of frailty, its prevention and treatment, has been                               
presented. However, no systematic review exists, which critically analyzes the existing 
evidence on interventions. 
